A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...

Scientists found that nearly every cancer harbors its own distinct community of microbes – tiny passengers that can influence how tumors start, spread, and respond to treatment, paving the way for a ...

Scientists have engineered a common probiotic bacterium to act like a microscopic drug factory that hunts down tumors and delivers cancer-killing compounds directly where they’re needed. Credit: ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

While human and mice tumors share many of the same molecular markers, including many shared genes, there are differences, including our natural immune responses and our immune systems in general.